Why Must the American Cancer Society Continue to Lie to the Public? This Time, They Do So in Coordinated Fashion

In a letter to the editor published last week in the Bradenton Herald, an individual identified as being with the American Cancer Society Cancer Action Network tells the public that the Bishop-Cole amendment would "strip FDA's authority to review new products, ones becoming increasingly popular with youth, like e-cigarettes, cigars and hookah." She goes on to urge Florida's Senator Nelson not to "fall for the industry's latest trick to avoid critical FDA oversight of these addictive and potentially lethal products."The Rest of the Story There's just one problem with this letter. It's not telling the truth. The rest of the story is that in contrast to what the American Cancer Society-affiliated author states, the Bishop-Cole amendment would not strip FDA's authority to review new products. In fact, under the Bishop-Cole amendment, any new product placed on the market from the effective date of the deeming regulations on would need to obtain pre-market approval from the FDA before being sold. And that would involve a burdensome and expensive process, costing millions of dollars, and would virtually ensure that very few new vaping products reach the market.This would damage the public's health because the newer vaping products are generally safer and more effective than the older ones. Moreover, it's only by allowing new products and improved products onto the market that we can improve the safety of e-cigarettes and definitively address problems such as exploding batteries, hig...
Source: The Rest of the Story: Tobacco News Analysis and Commentary - Category: Addiction Source Type: blogs